Product Program year 2025 Source: CMS Open Payments

Entereg

Drug Infectious Disease

NDC 67919-020-10

Open in the dashboard

General payments

$151,232

4,464 payments

Research payments

$443,982

7 payments

Through program year 2025, $151,232 in general payments and $443,982 in research payments were reported against Entereg (Infectious Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows

General

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $135K

Research

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $214K

Year	Kind	Amount	Payments
2025	Research	$101,280	1
2023	Research	$38,186	1
2021	Research	$214,296	2
2020	General	$16,216	1,044
2020	Research	$71,740	2
2019	General	$135,016	3,420
2019	Research	$18,480	1

Breakdown

Who paid General payments · program years 2019–2020

Merck Sharp & Dohme Corporation $151,232 4,464 payments

Top recipients General payments · program year 2020

Jesus Flores Colon & Rectal Surgery · Dallas, TX $128 <1% · 7 payments
Sharon Gregorcyk Colon & Rectal Surgery · Dallas, TX $120 <1% · 6 payments
Anant Shah Anesthesiology · Memphis, TN $60 <1% · 4 payments
Norman Warner Anesthesiology · Orlando, FL $55 <1% · 4 payments
Son Dang Anesthesiology · Bay St Louis, MS $47 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020

Anesthesiology $10,696 67% · 597 practitioners
Surgery $2,709 17% · 154 practitioners
Colon & Rectal Surgery $1,345 8% · 62 practitioners
Urology $237 1% · 14 practitioners
Pain Medicine Anesthesiology $159 <1% · 7 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020

Utah $1,685 10% · 72 recipients
Texas $1,292 8% · 62 recipients
Florida $1,285 8% · 65 recipients
Oklahoma $1,037 6% · 57 recipients
New York $907 6% · 53 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

4,464 general · 7 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.